HERPES VIRUS (HHV 5) - CYTOMEGALOVIRUS - ANVISA Registration 10345162442

Access comprehensive regulatory information for HERPES VIRUS (HHV 5) - CYTOMEGALOVIRUS in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 10345162442 and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS INC.. The registration is held by SIEMENS HEALTHCARE DIAGNÓSTICOS LTDA with validity until Jul 04, 2032.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ABBOTT IRELAND DIAGNOSTIC DIVISION, ROCHE DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10345162442
2 Related Devices
Registration Details
ANVISA Registration Number: 10345162442
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

Família ADVIA Centaur CMV IgM (CMV IgM)
Risk Class IV

Registration Details

10345162442

25351166284202261

01449930000190

Company Information

United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

Jul 04, 2022

04/07/2032

09/18/2025 19:00:01

Família ADVIA Centaur CMV IgM (CMV IgM)
Risk Class IV

Registration Details

10345162442

25351166284202261

01449930000190

Company Information

Dates and Status

Jul 04, 2022

04/07/2032

09/18/2025 19:00:01